| HIV Maintenance Therapy With T-20 During HAART Interruption (NCT00013884) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens (NCT00339287) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-02-12 |
| Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV (NCT00011011) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-02-01 |
| Pediatric Kidney Transplant Without Calcineurin Inhibitors (NCT00023231) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-02-01 |
| Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV (NCT00074399) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-02-01 |
| Safety and Survival of Genetically Modified White Blood Cells in HIV-infected Twins The Gemini Study (NCT04799483) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-05 |
| Steroid Withdrawal in Pediatric Kidney Transplant Recipients (NCT00023244) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |
| Study of Mycobacterial Infections (NCT00018044) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |
| HIV-1 Vaccine Test in Uninfected Adult Volunteers (NCT00009685) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |
| Anti-CD20 in Systemic Lupus Erythematosus (NCT00036491) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |
| Effects of Storage on Lactate in Blood Samples (NCT00011050) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |
| Monoclonal Antibody Treatment of Crohn's Disease (NCT00007163) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-12-01 |
| Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers (NCT00134875) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-12-01 |
| Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs (NCT00006494) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-07 |
| HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs (NCT00007488) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients (NCT00058734) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| 9-valent CRM 197 Pneumococcal (NCT00133549) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) (NCT00008463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women (NCT00006444) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents (NCT00006604) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| A Study of HIV-Disease Development in Aging (NCT00006144) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-10-01 |
| Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease (NCT00006417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-10-01 |
| Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir (NCT00031486) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-09-01 |
| Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women (NCT00006320) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-09-01 |
| Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES) (NCT00006150) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-08-10 |
| Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV (NCT00006145) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-08-01 |
| Half-Dose Flu Vaccine Study in Healthy Adults (NCT00006146) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-08-01 |
| Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis (NCT00004317) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-07-01 |
| Immune Function of Infants With HIV (NCT00073229) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-07-01 |
| Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus (NCT00005924) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-23 |
| Genetic Factors in Atherosclerosis (NCT00359307) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-08 |
| Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers (NCT00005907) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders (NCT00005933) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| TB Nutrition, Immunology and Epidemiology (NCT00170404) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children (NCT00006064) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Azithromycin/Bicillin Syphilis (NCT00031499) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults (NCT00331448) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs (NCT00005673) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-05-01 |
| Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy (NCT00009256) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-04-13 |
| Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants (NCT00007787) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-04-01 |
| Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections (NCT00004996) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-03-20 |
| Network on Antimicrobial Resistance in Staphylococcus Aureus (NCT00341913) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-03-16 |
| A Test of Behavioral Intervention for Women at High Risk for HIV Infection (NCT00006440) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-03-01 |
| An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy (NCT00004978) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-03-01 |
| The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV (NCT00004735) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-02-01 |
| Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes (NCT00004567) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-02-01 |
| Once-Daily Drug Regimen for HIV-Infected Patients (NCT00001968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-01-01 |
| Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection (NCT00001976) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-01-01 |
| Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination (NCT00001132) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-11-01 |
| A Study To Test An Anti-Rejection Therapy After Kidney Transplantation (NCT00000936) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-11-01 |
| Intermittent Versus Continuous Medication in the Treatment of HIV (NCT00001967) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-11-01 |
| Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome (NCT00001145) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| The Biology of HIV Transmission (NCT00001092) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| A Study to Monitor Patients With Primary or Early HIV Infection (NCT00000911) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients (NCT00069498) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV (NCT00001119) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| Outcomes of Anti-HIV Therapy During Early HIV Infection (NCT00001093) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-10-01 |
| New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia (NCT00342589) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-09-28 |
| Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis (NCT00001912) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-10 |
| A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1 (NCT00001121) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-01 |
| Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients (NCT00001110) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-01 |
| Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth (NCT00031447) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-08-01 |
| Treatment of Acute HIV Infection to Preserve Immune Function (NCT00055094) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-07-01 |
| Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections (NCT00001911) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-07-01 |
| Mechanisms of Allergen Immunotherapy (NCT00001910) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-07-01 |
| T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma (NCT00001908) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-06-01 |
| Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma (NCT00001909) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-05-01 |
| Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV (NCT00000940) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-05-01 |
| A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss (NCT00000925) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-05-01 |
| Prevention of RSV Infections in Bone Marrow Transplant Recipients (NCT00001903) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-04-01 |
| Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I (NCT00001905) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-04-01 |
| Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants (NCT00001906) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-04-01 |
| Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness (NCT00001904) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-04-01 |
| A Study of the Long-Term Outcomes of HIV-Positive Patients (NCT00000932) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-03-01 |
| Etanercept to Treat Wegener's Granulomatosis (NCT00001901) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-02-01 |
| Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy (NCT00001899) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-12-16 |
| Tuberculosis in HIV Infected Patients in Uganda (NCT00057421) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-11-01 |
| Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection (NCT00001645) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-10-10 |
| Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults (NCT00110578) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-09-01 |
| Vitamin A Therapy for Tuberculosis (NCT00057434) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-09-01 |
| Immune Regulation in Ulcerative Colitis or Crohn s Disease (NCT00001184) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-08-07 |
| Drug Interactions Among Anti-HIV Agents (NCT00001766) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-08-01 |
| The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 (NCT00000825) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-05-01 |
| Recombinant Human IL-4 Receptor Used in Treatment of Asthma (NCT00017693) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-05-01 |
| Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection (NCT00001763) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-04-01 |
| Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions (NCT00001764) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-04-01 |
| Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease (NCT00001765) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-04-01 |
| Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients (NCT00001651) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-25 |
| Magnetic Resonance Imaging of the Face and Bones (NCT00001762) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-23 |
| Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis (NCT00001761) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-01 |
| Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients (NCT00005009) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-01 |
| Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 (NCT00000948) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-02-01 |
| Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals (NCT00001760) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-01-01 |
| Study of Mast Cell Precursors (NCT00001756) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-03 |
| Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography (NCT00001759) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-01 |
| Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems (NCT00001097) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-01 |
| Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates (NCT00031460) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-01 |
| An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections (NCT00001757) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-11-01 |
| Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz (NCT00001758) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-11-01 |
| Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients (NCT00031473) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-11-01 |